AASLD position paper

Julie Polson; William M. Lee

doi:10.1002/hep.20703

journal article May 01, 2005

AASLD position paper

Julie Polson William M. Lee

Hepatology Vol. 41 No. 5 pp. 1179-1197 · Ovid Technologies (Wolters Kluwer Health)

View at Publisher Save 10.1002/hep.20703

Topics

No keywords indexed for this article. Browse by subject →

References

172

[1]

"Position and policy statement: American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers." Gastroenterology (1995) 10.1016/0016-5085(95)90469-7

[2]

Woolf "The expert panel on preventive services: continuing the work of the USPSTF" Am J Prev Med (1991) 10.1016/s0749-3797(18)30906-1

[3]

Hoofnagle "Fulminant hepatic failure: summary of a workshop" HEPATOLOGY (1995)

[4]

Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

George Ostapowicz, Robert J. Fontana, Frank V. Schiødt et al.

Annals of Internal Medicine 2002 10.7326/0003-4819-137-12-200212170-00007

[5]

Clemmesen "Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration" HEPATOLOGY (1999) 10.1002/hep.510290309

[6]

Clemmesen "Splanchnic and leg exchange of amino acids and ammonia in acute liver failure" Gastroenterology (2000) 10.1016/s0016-5085(00)70366-0

[7]

Early indicators of prognosis in fulminant hepatic failure

John G. O'Grady, Graeme J.M. Alexander, Karen M. Hayllar et al.

Gastroenterology 1989 10.1016/0016-5085(89)90081-4

[8]

Schiodt "Acetaminophen toxicity in an urban county hospital" N Engl J Med (1997) 10.1056/nejm199710163371602

[9]

Zimmerman "Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure" HEPATOLOGY (1995) 10.1002/hep.1840220312

[10]

Green "How long after drug ingestion is activated charcoal still effective?" J Toxicol Clin Toxicol (2001) 10.1081/clt-100108492

[11]

Sato "Efficacy of superactivated charcoal administration late (3 hours) after acetaminophen overdose" Am J Emerg Med (2003) 10.1016/s0735-6757(02)42251-6

[12]

A prospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose

Henry A. Spiller, Edward P. Krenzelok, Gregory A. Grande et al.

Annals of Emergency Medicine 1994 10.1016/s0196-0644(94)70071-0

[13]

Douglas "Controlled trial of cysteamine in treatment of acute paracetamol (acetaminophen) poisoning" Lancet (1976) 10.1016/s0140-6736(76)93154-8

[14]

Prescott "Cysteamine, methionine and penicillamine in th treatment of paracetamol poisoning" Lancet (1976) 10.1016/s0140-6736(76)92842-7

[15]

Smilkstein "Efficacy of oral N‐acetylcysteine in the treatment of acetaminophen overdose" N Engl J Med (1988) 10.1056/nejm198812153192401

[16]

Keays "A prospective controlled trial of intravenous N‐acetylcysteine in paracetamol‐induced fulminant hepatic failure" BMJ (1991) 10.1136/bmj.303.6809.1026

[17]

Lee "Drug‐Induced Hepatotoxicity" N Engl J Med (2003) 10.1056/nejmra021844

[18]

Harrison "Improved outcome of paracetamol‐induced fulminant hepatic failure by late administration of acetylcysteine" Lancet (1990) 10.1016/0140-6736(90)91388-q

[19]

Vale "Paracetamol (acetaminophen) poisoning" Lancet (1995) 10.1016/s0140-6736(95)91385-8

[20]

Klein "Amanita poisoning: treatment and the role of liver transplantation" Am J Med (1989) 10.1016/0002-9343(89)90267-2

[21]

Rengstorff "Recovery from severe hepatitis caused by mushroom poisoning without liver transplantation" Clinical Gastroenterology and HEPATOLOGY (2003) 10.1053/s1542-3565(03)00179-4

[22]

Moroni "A trend in therapy of Amanita phalloides poisoning" Arch Toxicol (1976) 10.1007/bf00351969

[23]

Hruby "Chemotherapy of Amanita phalloides poisoning with intravenous silibinin" Human Toxicol (1983) 10.1177/096032718300200203

[24]

Enjalbert "Treatment of amatoxin poisoning: 20‐year retrospective analysis" J Toxicol Clin Toxicol (2002) 10.1081/clt-120014646

[25]

Broussard "Mushroom poisoning — from diarrhea to liver transplantation" Am J Gastroenterol (2001)

[26]

Schneider "Failure of N‐acetycysteine to reduce alpha amanitin toxicity" J Appl Toxicol (1992) 10.1002/jat.2550120211

[27]

Montanini "Use of acetylsysteine as the life‐saving antidote in Amanita phalloides (death cap) poisoning. Case report on 11 patients" Arzneimittelforschung (1999)

[28]

Stedman "Herbal hepatotoxicity" Semin Liv Disease (2002) 10.1055/s-2002-30104

[29]

Schiodt "Viral hepatitis‐related acute liver failure" Am J Gastroenterol (2003) 10.1016/s0002-9270(02)05891-4

[30]

Khuroo "Aetiology and prognostic factors in acute liver failure in India" J Viral Hepatol (2003) 10.1046/j.1365-2893.2003.00415.x

[31]

Lee "Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients" Am J Kidney Dis (2001) 10.1053/ajkd.2001.28607

[32]

Lok "AASLD Practice Guideline, Chronic Hepatitis B: Update of Recommendations" HEPATOLOGY (2004) 10.1002/hep.20110

[33]

Kang "Herpes simplex hepatitis in pregnancy: a case report and review of the literature" Obstet Gynecol Surv (1999) 10.1097/00006254-199907000-00026

[34]

Peters "Herpes simplex‐induced fuminant hepatitis in adults: a call for empiric therapy" Dig Dis Sci (2000) 10.1023/a:1005699210816

[35]

Dits "Varicella‐zoster virus infection associated with acute liver failure" Clin Infect Dis (1998) 10.1086/514613

[36]

Roberts "AASLD Practice guidelines: A practice guideline on Wilson disease" HEPATOLOGY (2003) 10.1053/jhep.2003.50252

[37]

Berman "Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure" Gastroenterology (1991) 10.1016/0016-5085(91)90294-u

[38]

Schilsky "Diagnosis and treatment of Wilson's disease" Pediatr Transplantation (2002) 10.1034/j.1399-3046.2002.1r069.x

[39]

Czaja "AASLD Practice Guidelines: Diagnosis and Treatment of Autoimmune Hepatitis" HEPATOLOGY (2002) 10.1053/jhep.2002.34944

[40]

Czaja "Treatment of autoimmune hepatitis" Semin Liv Disease (2002) 10.1055/s-2002-35706

[41]

Viruet "Steroid therapy in fulminant hepatitic failure secondary to autoimmune hepatitis" P R Health Sci J (1998)

[42]

Rolfes "Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases" HEPATOLOGY (1985) 10.1002/hep.1840050615

[43]

Weinstein "Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy" Am J Obstet Gynecol (1982) 10.1016/s0002-9378(16)32330-4

[44]

Pereira "Maternal and Perinatal Outcome in Severe Pregnancy‐Related Liver Disease" HEPATOLOGY (1997)

[45]

Rahman "Severe hepatic dysfunction in pregnancy" Q J Med (2002) 10.1093/qjmed/95.6.343

[46]

Ockner "Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation" HEPATOLOGY (1990) 10.1002/hep.1840110112

[47]

Kisloff "Fulminant hepatic failure secondary to congestive heart failure" Dig Dis Sci (1976) 10.1007/bf01072084

[48]

Dalton "Hepatotoxicity associated with sustained‐release niacin" Am J Med (1992) 10.1016/0002-9343(92)90689-9

[49]

Silva "Hepatic dysfunction accompanying acute cocaine intoxication" J Hepatol (1991) 10.1016/0168-8278(91)90832-v

[50]

Kamijo "Acute liver failure following intravenous methamphetamine" Vet Hum Toxicol (2002)

Showing 50 of 172 references

Metrics

751

Citations

172

References

Details

Published: May 01, 2005
Vol/Issue: 41(5)
Pages: 1179-1197
License: View

Authors

Division of Digestive and Liver Diseases, UT Southwestern Medical Center at Dallas, Dallas, Texas, USA.

Cite This Article

Julie Polson, William M. Lee (2005). AASLD position paper. Hepatology, 41(5), 1179-1197. https://doi.org/10.1002/hep.20703

AASLD position paper

You May Also Like